Abbreviations ARB: Angiotensin receptor blocker CKD: Chronic kidney disease CRP: C-reactive protein DKA: Diabetic ketoacidosis DKD: Diabetic kidney disease ERA: Endothelin receptor antagonist ESKD: End-stage kidney disease GIP: Glucose-dependent insulinotropic polypeptide GLP1: Glucagon-like peptide 1 GLP1-RA: Glucagon-like peptide 1 receptor agonist HF: Heart failure hsCRP: High-sensitivity C-reactive protein MACE: Major adverse cardiovascular events MRA: Mineralocorticoid receptor antagonist NO: Nitric oxide RAS: Reninangiotensin system sGC: Soluble guanylate cyclase SGLT2i: Sodiumglucose cotransporter-2 inhibitor(s) UACR: Urine albumin to creatinine ratio References Rossing P, Caramori ML, Chan JCH et al (2022) KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease
Synergistic Activation: Analyzing dual-pathway receptor-mediated signaling
However, there is ample evidence to suggest that the environmental factors and gene-environment interactions may be important causes of neurodegenerative diseases
VAT dropped by about 18% over 52 weeks vs placebo
Preclinical studies indicate GLP-1 receptors may be expressed on various immune cells, including macrophages, monocytes, and lymphocytes, though human data remains limited
That dual mechanism helps explain why it can be especially effective for blood sugar control and weight loss